Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 5/20 | 0.66 |
| ▸ | LMNA | P02545 | 3/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.66 |
| ▸ | PGR | P06401 | 2/20 | 0.66 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.66 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.66 |
| ▸ | PDE4A | P27815 | 1/20 | 0.66 |
| ▸ | HRH1 | P35367 | 1/20 | 0.66 |
| ▸ | HTT | P42858 | 1/20 | 0.66 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.66 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 3/20 | 0.61 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.61 |
| ▸ | USP2 | O75604 | 1/20 | 0.61 |
| ▸ | GAA | P10253 | 1/20 | 0.61 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.61 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29064865 | 0.88 | HPGD (0.62) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL12743862 | 0.88 | LMNA (0.69) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL12415232 | 0.88 | HPGD (0.69) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL29064850 | 0.87 | HPGD (0.61) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL545524 | 0.86 | HPGD (0.68) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL10557539 | 0.86 | HPGD (0.68) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL551152 | 0.85 | HPGD (0.66) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL21880203 | 0.85 | HPGD (0.66) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL808526 | 0.85 | HPGD (0.71) | HPGDLMNACYP1A2PGRSLC6A2 | |
| SCHEMBL5028940 | 0.85 | LMNA (0.66) | HPGDLMNACYP1A2PGRSLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118308060-A | Polyurethane adhesive capable of resisting yellowing and application thereof | 广州市奥悦盛体育产业有限公司 | 2024-07-09 | — | — | CN | claimed |
| CN-116836145-B | Polymerizable photochromic compound and application thereof | 重庆蕾明视光科技有限公司 | 2024-06-14 | — | — | CN | claimed |
| US-11992825-B2 | Adsorption medium, method for production thereof, and use thereof for purification of biomolecules | SARTORIUS STEDIM BIOTECH GMBH (DE) | 2024-05-28 | — | — | US | claimed |
| CN-117264113-A | Silicone ink-containing intermediate for color contact lens, preparation method thereof and color contact lens | 甘肃康视达科技集团有限公司 | 2023-12-22 | — | — | CN | claimed |
| CN-116836145-A | Polymerizable photochromic compound and application thereof | 重庆蕾明视光科技有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116338831-A | Silicon hydrogel and hydrogel combined cornea contact lens and manufacturing method thereof | 邓婷 | 2023-06-27 | — | — | CN | claimed |
| CN-116265427-A | Treatment method of 2- (4-benzoyl-3-hydroxyphenoxy) ethyl 2-acrylate kettle residues | 爱生华(苏州)光学有限公司 | 2023-06-20 | — | — | CN | claimed |
| CN-115215963-B | Blue light resistant cornea contact lens and preparation method thereof | 江苏海伦隐形眼镜有限公司 | 2023-06-13 | — | — | CN | claimed |
| CN-113912775-B | Indicator material and preparation method and application thereof | 江苏海伦隐形眼镜有限公司 | 2023-01-10 | — | — | CN | claimed |
| CN-113746035-B | Method for improving interface voltage resistance of prefabricated cable accessory rubber stress control body | 哈尔滨理工大学 | 2022-12-09 | — | — | CN | claimed |
| US-9520518-B2 | Solar cell module | MITSUI CHEMICALS TOHCELLO, INC. (JP) | 2016-12-13 | — | — | US | claimed |
| US-20150144193-A1 | SOLAR CELL MODULE | MITSUI CHEMICALS TOHCELLO, INC. (JP) | 2015-05-28 | — | — | US | claimed |
| EP-2851964-A1 | SOLAR CELL MODULE | Mitsui Chemicals Tohcello, Inc. (JP) | 2015-03-25 | — | — | EP | claimed |
| CN-102757527-B | anti-UV contact lens formulation | LARGAN MEDICAL INC | 2015-02-04 | — | — | CN | claimed |
| CN-102757527-A | anti-UV contact lens formulation | LARGAN MEDICAL INC | 2012-10-31 | — | — | CN | claimed |
| US-5473001-A | Heat and oxidation resistance; photostability | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1995-12-05 | — | — | US | claimed |
| US-5397821-A | Light and heat stabilizers, low volatility | ELFATOCHEM NORTH AMERICA, INC. (US) | 1995-03-14 | — | — | US | claimed |
| US-5338853-A | N-(2,2,6,6-tetraalkyl-4-piperidinyl)amic acid hydrazides; contain light stabilizing group and heat stabilizing group | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1994-08-16 | — | — | US | claimed |
| US-5241067-A | Imparting heat, light and oxidation resistance to polymers | ELF ATOCHEM NORTH AMERICA, INC. (US) | 1993-08-31 | — | — | US | claimed |
| EP-0303283-A2 | 2-Hydroxybenzophenone hydrazides and derivatives thereof | ATOCHEM NORTH AMERICA, INC. (US) | 1989-02-15 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11992825-B2 | Adsorption medium, method for production thereof, and use thereof for purification of biomolecules | NEFM, BPGM, ADM2 | HPGD 583/4885LMNA 1049/4885CYP1A2 4207/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.